Investors

Corporate News

2017

20 October Form 8.3 - CLIN LN/QP LN
20 October Form 8.3 - QP LN/CLIN LN
20 October Form 8.3 - [Quantum Pharma plc]
20 October Notification of Major Interest in Shares
20 October Form 8.3 - Quantum Pharma Plc
20 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
20 October Form 8.3 - Quantum Pharma Plc
19 October Form 8.3 - QP LN/CLIN LN
19 October Form 8.3 - CLIN LN/QP LN
19 October Form 8.3 - [Quantum Pharma plc]
19 October Form 8.3 - Quantum Pharma Plc
19 October Form 8.3 - [Quantum Pharma plc]
19 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
19 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
18 October Form 8.3 - CLIN LN/QP LN
18 October Form 8.3 - QP LN/CLIN LN
18 October Form 8.3 - Quantum Pharma PLC
18 October Form 8.3 - [Quantum Pharma plc]
18 October Form 8.3 - Quantum Pharma PLC
18 October Form 8.3 - Quantum Pharma Plc
18 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
18 October Notification of Major Interest in Shares
18 October Notification of Major Interest in Shares
18 October Notification of Major Interest in Shares
17 October Notification of Major Interest in Shares
17 October Form 8.3 - QP LN/CLIN LN
17 October Form 8.3 - CLIN LN/QP LN
17 October Form 8.3 - Quantum Pharma PLC
17 October Form 8.3 - [Quantum Pharma plc]
17 October Form 8.3 - Quantum Pharma PLC
17 October Form 8.5 (EPT/RI) Quantum Pharma
17 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
16 October Form 8.3 - QP LN/CLIN LN
16 October Form 8.3 - CLIN LN/QP LN
16 October Form 8.3 - Quantum Pharma Plc
16 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
13 October Form 8.3 - [Quantum Pharma plc]
13 October Form 8.3 - Quantum Pharma plc
13 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
12 October Notification of Major Interest in Shares
12 October Form 8.3 - QP LN/CLIN LIN
12 October Form 8.3 - CLIN LN/QP LN
12 October Form 8.3 - [Quantum Pharma plc]
12 October Form 8.3 - Quantum Pharma PLC
12 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
12 October Form 8.3 - Clinigen Group Plc
11 October Form 8.3 - QP LN/CLIN LIN
11 October Form 8.3 - CLIN LN/QP LN
11 October Form 8.3 - [Quantum Pharma Plc]
11 October Form 8.3 - [Quantum Pharma plc]
11 October Form 8.3 - Quantum Pharma PLC
11 October Form 8.5 (EPT/RI) Quantum Pharma
11 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
11 October Form 8.3 - Quantum Pharma Plc
10 October Form 8.3 - QP LN/CLIN LIN
10 October Form 8.3 - CLIN LN/QP LN
10 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
09 October Form 8.3 - CLIN LN/QP LN
09 October Form 8.3 - QP LN/CLIN LIN
09 October Form 8.3 - Clinigen Group Plc
09 October Form 8.3 - Quantum Pharma plc
09 October Form 8.3 - Quantum Pharma PLC
09 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
09 October Form 8.3 - [Quantum Pharma PLC]
06 October Form 8.3 - QP LN/CLIN LN
06 October Form 8.3 - QP LN/CLIN LN
06 October Form 8.3 - Quantum Pharma Plc
06 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
05 October Form 8.3 - [Quantum Pharma plc]
05 October Form 8.3 - Quantum Pharma PLC
05 October Form 8.3 - Quantum Pharma Plc
05 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
05 October Notification of Major Interest in Shares
05 October Notification of Major Interest in Shares
05 October Notification of Major Interest in Shares
04 October Form 8.3 - QP LN/CLIN LN
04 October Form 8.3 - QP LN/CLIN LN
04 October Form 8.3 - Quantum Pharma PLC
04 October Form 8.3 - Quantum Pharma plc
04 October Form 8.3 - Quantum Pharma PLC
04 October Form 8.3 - Quantum Pharma Plc
04 October Form 8.5 (EPT/RI) Quantum Pharma
04 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
04 October Form 8.3 - Quantum Pharma Plc
04 October Form 8.3 - Quantum Pharma plc
03 October Form 8.3 - QP LN/CLIN LN
03 October Form 8.3 - CLIN LN/QP LN
03 October Form 8.3 - [Quantum Pharma plc]
03 October Form 8.3 - Quantum Pharma plc
03 October Form 8.3 - [Quantum Pharma plc]
03 October Form 8.3 - Quantum Pharma Plc
03 October Form 8.3 - Quantum Pharma plc
03 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
03 October Form 8.3 - Quantum Pharma Plc
02 October Form 8.3 - [Quantum Pharma plc]
02 October Form 8.5 (EPT/RI) - Quantum Pharma Plc
29 September Form 8.3 - [Quantum Pharma plc]
29 September Form 8.5 (EPT/RI) Quantum Pharma
29 September Posting of Scheme Document
29 September Form 8.3 - Quantum Pharma plc
28 September Form 8.3 - [Quantum Pharma plc]
28 September Notification of Major Interest in Shares
28 September Form 8.3 - [Quantum Pharm plc]
28 September Form 8.3 - Quantum Pharma Group PLC
28 September Form 8.5 (EPT/RI) Quantum Pharma
28 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
28 September Form 8.3 - Quantum Pharam Plc
27 September Notification of Major Interest in Shares
27 September Form 8.3 - Quantum Pharma plc
27 September Form 8.5 (EPT/RI) Quantum Pharma
27 September Form 8.3 - Quantum Pharma plc
26 September Form 8.3 - Quantum Pharma PLC
26 September Form 8.3 - Quantum Pharma plc
26 September Notification of Major Interest in Shares
26 September Notification of Major Interest in Shares
26 September Form 8.3 - Quantum Pharma plc
26 September Form 8.3 - [Quantum Pharma plc]
26 September Form 8.5 (EPT/RI) Quantum Pharma
26 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
26 September Form 8.3 - Quantum Pharma PLC
25 September Form 8.3 - Quantum Pharma Plc
25 September Form 8.3 - Quantum Pharma Plc
25 September Form 8.3 - Quantum Pharma Plc
25 September Notification of Major Interest in Shares
25 September Form 8.3 - Quantum Pharma plc
25 September Form 8.3 - Quantum Pharma PLC
25 September Form 8.3 - Quantum Pharma PLC
25 September Form 8.3 - Quantum Pharma plc
25 September Form 8.3 - [Quantum Pharma plc]
25 September Form 8.3 - QUANTUM PHARMA PLC
25 September Form 8.3 - Quantum Pharma
25 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
25 September Form 8.5 (EPT/RI) Quantum Pharma
22 September Form 8.3 - Quantum Pharma PLC
22 September Form 8.3 - Quantum Pharma
22 September Form 8.3 - Quantum Pharma plc
22 September Form 8.3 - Quantum Pharma plc
22 September Form 8.3 - Quantum Pharma plc
22 September Form 8.3 - Quantum Pharma plc
22 September Form 8.3 - [Quantum Pharma plc]
22 September Notification of Major Interest in Shares
22 September Form 8.3 - Quantum Pharma plc
22 September Form 8.3 - QUANTUM PHARMA PLC
22 September Form 8.5 (EPT/RI) Quantum Pharma
22 September Form 8.3 - Quantum Pharma Group Plc
21 September Notification of Major Interest in Shares
21 September Form 8.3 - Clinigen Group Plc
21 September Form 8.3 - Quantum Pharma Group Plc
21 September Form 8.3 - [Quantum Pharma plc]
21 September Form 8.3 - Quantum Pharma Plc
21 September Form 8.3 - Quantum Pharma plc
21 September Form 8.3 - QUANTUM PHARMA PLC
21 September Form 8.3 - Quantum Pharma plc
21 September Form 8.3 - Quantum Pharma PLC
21 September Form 8.5 (EPT/RI) Quantum Pharma
21 September Form 8.3 - Quantum Pharma plc
20 September Notification of Major Interest in Shares
20 September Form 8.3 - Quantum Pharma plc
20 September Form 8.3 - Quantum Pharma plc
20 September Form 8.3 - Quantum Pharma Plc
20 September Form 8.3 - QUANTUM PHARMA PLC
19 September Form 8.3 - Quantum Pharma Plc
19 September Form 8.3 - Quantum Pharma Plc
19 September Form 8.3 - Quantum Pharma Plc
19 September Form 8.3 - Quantum Pharma Plc
19 September Form 8.3 - Quantum Pharma PLC
19 September Form 8.3 - Quantum Pharma Plc
19 September Form 8.3 - Quantum Pharma plc
19 September Form 8.5 (EPT/RI) Quantum Pharma
19 September Form 8.3 - Quantum Pharma PLC
19 September Form 8.3 - Quantum Pharma plc
19 September Form 8.3 - QUANTUM PHARMA PLC
18 September Notification of Major Interest in Shares
18 September Notification of Major Interest in Shares
18 September Form 8.3 - Quantum Pharma plc
18 September Form 8.3 - QUANTUM PHARMA
18 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
18 September Form 8.3 - Quantum Pharma plc
15 September Notification of Major Interest in Shares
15 September Notification of Major Interest in Shares
15 September Notification of Major Interest in Shares
15 September Form 8.5 (EPT/RI) Quantum Pharma
15 September Form 8.3 - Quantum Pharma plc
15 September Form 8.3 - Quantum Pharma Plc
15 September Form 8.3 - Quantum Pharma plc
15 September Form 8.3 - Quantum Pharma plc
15 September Form 8.3 - QUANTUM PHARMA
15 September Notification of Major Interest in Shares
15 September Form 8.5 (EPT/RI) Quantum Pharma
14 September Holding(s) in Company
14 September Form 8.3 - [Quantum Pharma Plc]
14 September Form 8.3 - Quantum Pharma plc
14 September Form 8.3 - Quantum Pharma Plc
14 September Form 8.5 (EPT/RI) Quantum Pharma
14 September Form 8.3 - QUANTUM PHARMA
14 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
14 September Form 8.3 - Quantum Pharma plc
13 September Form 8.5 (EPT/RI) Quantum Pharma
13 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
13 September Rule 2.7 Announcement re: Recommended Acqusition of Quantum Pharma Plc by Clinigen Group plc
12 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
12 September Form 8.5 (EPT/RI) Quantum Pharma
11 September Form 8.5 (EPT/RI) Quantum pharma
08 September Form 8.5 (EPT/RI) Quantum Pharma
07 September Form 8.3 - Quantum Pharma Plc
07 September Form 8.5 (EPT/RI) Quantum Pharma
06 September Form 8.5 (EPT/RI) Quantum Pharma
05 September Form 8.5 (EPT/RI) - Quantum
05 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
04 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
01 September Form 8.3 - Quantum Pharma Plc
01 September OML - Form 8.3 - Quantum Pharma Plc
01 September Form 8.5 (EPT/RI) - Quantum Pharma Plc
31 August Form 8.3 - Quantum Pharma plc
31 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
30 August Form 8.3 - Quantum Pharma Plc
30 August OML - Form 8.3 - Quantum Pharma Plc
30 August Form 8.5 (EPT/RI) - Quantum Pharma
30 August Form 8.3 - Quantum Pharma Plc
29 August Form 8 (OPD) - Quantum Pharma Plc
29 August OML - Form 8.3 - Quantum Pharma Plc
29 August Form 8.5 (EPT/RI) - Quantum Pharma
29 August Form 8.5 (EPT/RI) - Quantum Pharma
25 August Form 8.3 - Quantum Pharma plc
25 August Form 8.3 - Quantum Pharma Plc
25 August Form 8.5 (EPT/RI) - Quantum Pharma
24 August Form 8.3 - Quantum Pharma
24 August Form 8.3 - Quantum Pharma plc
24 August Form 8.3 - Quantum Pharma
24 August Form 8.3 - Quantum Pharma
24 August Form 8.5 (EPT/RI) - Quantum Pharma
24 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
23 August Form 8.3 - Quantum Pharma
23 August Form 8.3 - Quantum Pharma Plc
23 August Form 8.3 - Quantum Pharma plc
23 August Form 8.5 (EPT/RI) - Quantum Pharma
23 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
22 August Form 8.3 - Quantum Pharma plc
22 August Form 8.3 - Quantum Pharma plc
22 August Form 8.5 (EPT/RI) - Quantum
22 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
22 August Unaudited results for the half year ended 31 July 2017 ('the period' or 'H1 2018')
21 August Form 8.3 - Quantum Pharma plc
21 August Form 8.3 - Quantum Pharma plc
21 August Rathbones : Form 8.3 - [Quantum Pharma PLC]
21 August Form 8.3 - Quantum Pharma plc
21 August Form 8.3 - Clinigen Group Plc
21 August Form 8.5 (EPT/RI) - Quantum Pharma
21 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
18 August Form 8.3 - Quantum Pharma plc
18 August Form 8.3 - Quantum Pharma plc
18 August Form 8.3 - Quantum Pharma plc
18 August Form 8.3 - AXA INVESTMENT MANAGERS : Quantum Pharma Plc
18 August Form 8.3 - Quantum Pharma plc
18 August Form 8.3 - Quantum Pharma Plc
18 August Form 8.3 - Clinigen Group Plc
18 August Form 8.5 (EPT/RI) - Quantum Pharma Plc
18 August Form 8.3 - Quantum Pharma plc
17 August Form 8 (OPD) Quantum Pharma Plc
17 August Form 8.3 - [Quantum Pharma plc]
17 August Form 8.3 - Clinigen Group Plc
17 August Form 8.3 - Quantum Pharma Plc
17 August Form 8.3 - Quantum Pharma
17 August Form 8 (OPD) (Quantum Pharma Plc)
17 August Form 8.5 (EPT/RI) - Quantum Pharma
17 August Form 8.3 - Quantum Pharma plc
17 August Hargreave Hale LTD : Form 8.3 - Quantum Pharma PLC
17 August Notice of Interim Results: Date Change
16 August Slater Investments Ltd - Form 8.3 - Quantum Pharma Plc
16 August Possible Offer for the Company
09 August Half Year Trading Update &
Notice of Interim Results
10 July Grant of SAYE options
06 July Result of Annual General Meeting
26 June Disposal of Biodose Services and Trading Update
06 June Annual Report and Accounts
Notice of Annual General Meeting
03 May Final audited results for the year ended 31 January 2017 ('the year')
02 May TR-1 Notification of Major Interest in Shares
26 April Administration of NuPharm
24 March TR-1 Notification of Major Interest in Shares
01 February Full Year Trading Update & Notice of Final Results
24 January Grant of Options
04 January Share purchase by CFO-Designate

 

 
Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
PROTOMED